SVA

Sinovac Biotech, Ltd
SVA

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

SVA was delisted on the 22nd of February, 2019.

Back to rankings

38 hedge funds and large institutions have $128M invested in Sinovac Biotech, Ltd in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $30K

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
$30K
Net Calls
Net Calls Change

Top Buyers

1
+$865K
2
+$294K
3
+$198K
4
Two Sigma Investments
Two Sigma Investments
New York
+$146K
5
AIM
Acrospire Investment Management
Illinois
+$113K

Top Sellers

1
-$1.21M
2
-$668K
3
-$627K
4
CS
Credit Suisse
Switzerland
-$380K
5
Morgan Stanley
Morgan Stanley
New York
-$278K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$11K
27
$10K
28
$10K
29
$8K
30
$7K
31
$6K
32
$3K
33
$3K
34
$3K
35
$2K
36
$2K
37
$1K
38
–
39
–
40
–
41
–
42
–
1
2